Sarepta Therapeutics Aktie
WKN DE: A1J1BH / ISIN: US8036071004
22.05.2014 18:18:22
|
Sarepta To Acquire Manufacturing Facility In Massachusetts
(RTTNews) - Sarepta Therapeutics Inc (SRPT), a developer of innovative RNA-based therapeutics, Thursday agreed to acquire a multifunctional manufacturing facility in Massachusetts. Sarepta intends to use the facility to manufacture investigational exon skipping therapies for Duchenne muscular dystrophy.
The transaction comprises about $25 million in acquisition costs and planned enhancements.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sarepta Therapeutics Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Sarepta Therapeutics Inc.mehr Analysen
Aktien in diesem Artikel
Sarepta Therapeutics Inc. | 52,92 | 0,04% |
|